GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 709-717

  Kyrönlahti, Antti ^a,c   Kauppinen, Marjut ^a   Lind, Essi ^b   Unkila Kallio, Leila ^a   Butzow, Ralf ^a   Klefström, Juha ^b   Wilson, David B ^c   Anttonen, Mikko ^a   Heikinheimo, Markku ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; CASPASE 7; DEATH RECEPTOR 4; DEATH RECEPTOR 5; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR GATA 4; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY;

EID: 77956370685     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0041     Document Type: Article

References (35)

1. Anttonen M, Unkila-Kallio L, Leminen A, Butzow R & Heikinheimo M 2005 High GATA-4 expression associates with aggressive behavior, whereas low anti-Mullerian hormone expression associates with growth potential of ovarian granulosa cell tumors. Journal of Clinical Endocrinology and Metabolism 90 6529-6535. (Pubitemid 41759309)
2. Ashkenazi A 2008 Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nature Reviews. Drug Discovery 7 1001-1012.
3. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S & Nemer M 2001 Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes and Development 15 2702-2719. (Pubitemid 32988880)
4. Colombo N, Parma G, Zanagnolo V & Insinga A 2007 Management of ovarian stromal cell tumors. Journal of Clinical Oncology 25 2944-2951. (Pubitemid 47123159)
5. Cuello M, Ettenberg SA, Nau MM & Lipkowitz S 2001 Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells. Gynecologic Oncology 81 380-390. (Pubitemid 32494651)
6. Fulda S & Debatin KM 2006 Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 4798-4811. (Pubitemid 44187627)
7. Fuller PJ & Chu S 2004 Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends in Endocrinology and Metabolism 15 122-128. (Pubitemid 38445066)
8. Heikinheimo M, Scandrett JM & Wilson DB 1994 Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Developmental Biology 164 361-373. (Pubitemid 24269225)
9. Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS & Wilson DB 1997 Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138 3505-3514. (Pubitemid 27345706)
10. Heineke J, Auger-Messier M, Xu J, Oka T, Sargent MA, York A, Klevitsky R, Vaikunth S, Duncan SA, Aronow BJ et al. 2007 Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. Journal of Clinical Investigation 117 3198-3210.
11. Hsu SY, Lai RJ, Finegold M & Hsueh AJ 1996 Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis. Endocrinology 137 4837-4843.
12. Jaaskelainen M, Kyronlahti A, Anttonen M, Nishi Y, Yanase T, Secchiero P, Zauli G, Tapanainen JS, Heikinheimo M & Vaskivuo TE 2009 TRAIL pathway components and their putative role in granulosa cell apoptosis in the human ovary. Differentiation 77 369-376.
13. Jamieson S & Fuller PJ 2008 Management of granulosa cell tumour of the ovary. Current Opinion in Oncology 20 560-564.
14. Johnstone RW, Frew AJ & Smyth MJ 2008 The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nature Reviews. Cancer 8 782-798.
15. Kitta K, Day RM, Kim Y, Torregroza I, Evans T & Suzuki YJ 2003 Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. Journal of Biological Chemistry 278 4705-4712.
16. Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM & Liang Q 2006 Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB Journal 20 800-802. (Pubitemid 46671220)
17. Kobayashi S, Volden P, Timm D, Mao K, Xu X & Liang Q 2009 Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. Journal of Biological Chemistry 285 793-804.
18. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G & Kallioniemi OP 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 4 844-847. (Pubitemid 28331029)
19. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C & Leiden JM 1997 GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes and Development 11 1048-1060. (Pubitemid 27199883)
20. Kyronlahti A, Ramo M, Tamminen M, Unkila-Kallio L, Butzow R, Leminen A, Nemer M, Rahman N, Huhtaniemi I, Heikinheimo M et al. 2008 GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors. Endocrinology 149 5635-5642.
21. La Marca A & Volpe A 2007 The anti-Mullerian hormone and ovarian cancer. Human Reproduction Update 13 265-273.
22. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE & Molkentin JD 2001 The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. Journal of Biological Chemistry 276 30245-30253.
23. Molkentin JD, Lin Q, Duncan SA & Olson EN 1997 Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes and Development 11 1061-1072. (Pubitemid 27199884)
24. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, Saito M, Nomura M, Mukasa C, Okabe T, Goto K et al. 2001 Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 437-445.
25. Partanen JI, Nieminen AI, Makela TP & Klefstrom J 2007 Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. PNAS 104 14694-14699.
26. Pru JK & Tilly JL 2001 Programmed cell death in the ovary: insights and future prospects using genetic technologies. Molecular Endocrinology 15 845-853.
27. Ratts VS, Flaws JA, Kolp R, Sorenson CM & Tilly JL 1995 Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the postnatal female mouse gonad. Endocrinology 136 3665-3668.
28. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, Duvillard P, Chemes H & Bidart JM 2000 Anti-Mullerian hormone is a specific marker of sertoliand granulosa-cell origin in gonadal tumors. Human Pathology 31 1202-1208.
29. Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, Salamanca C, Maines-Bandiera S, Cooke SL, Leung P, Brenton JD et al. 2009 The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS ONE 4 e7988.
30. Schumer ST & Cannistra SA 2003 Granulosa cell tumor of the ovary. Journal of Clinical Oncology 21 1180-1189.
31. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE et al. 2009 Mutation of FOXL2 in granulosa-cell tumors of the ovary. New England Journal of Medicine 360 2719-2729.
32. Tilly JL 1996 Apoptosis and ovarian function. Reviews of Reproduction 1 162-172.
33. Viger RS, Guittot SM, Anttonen M, Wilson DB & Heikinheimo M 2008 Role of the GATA family of transcription factors in endocrine development, function, and disease. Molecular Endocrinology 22 781-798. (Pubitemid 351485626)
34. Woods DC, Alvarez C & Johnson AL 2008a Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells. Gynecologic Oncology 108 632-640.
35. Woods DC, Liu HK, Nishi Y, Yanase T & Johnson AL 2008b Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death. Cancer Letters 260 20-27.